Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans

More than 50 years ago the owl monkey (genus Aotus) was found to be highly susceptible to developing human malaria, making it an excellent experimental model for this disease. Microbes and parasites' (especially malaria) tremendous genetic variability became resolved during our malaria vaccine...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23518
Acceso en línea:
https://doi.org/10.1016/j.bbrc.2017.08.012
https://repository.urosario.edu.co/handle/10336/23518
Palabra clave:
HLA DRB1 antigen
Malaria vaccine
HLA antigen class 2
Malaria vaccine
Aotus
Article
Controlled study
Genetic variability
Human
Hydrophobicity
Immunofluorescence test
Immunogenicity
Malaria falciparum
Nonhuman
Plasmodium falciparum
Priority journal
Proton nuclear magnetic resonance
Static electricity
Vaccination
Western blotting
Animal
Antigen antibody reaction
Aotidae
Chemistry
Immunology
Animals
Antigen-Antibody Reactions
Aotidae
Histocompatibility Antigens Class II
Humans
Malaria Vaccines
Animal model
HLA-peptide binding
IMPIPS
Malarial-vaccine
MHC-DR
Rights
License
Abierto (Texto Completo)
id EDOCUR2_ae513c867b3cc4068ef8578e20f7bb6b
oai_identifier_str oai:repository.urosario.edu.co:10336/23518
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 20b87ac9-637e-491a-88a8-542cfcd798d2-13ec909b1-d14b-4a5a-bbc4-61bd89d7ff48-13b4ee447-709e-4b28-848d-ddf51f15ec60-1c097ad50-1f6e-4d04-9a55-38876ffe0ea9-19fc64f6d-a903-48f1-ac2e-4e55fd2ed9af-176e03223-040d-4e46-864f-3bdecc8d2790-12020-05-26T00:02:43Z2020-05-26T00:02:43Z2017More than 50 years ago the owl monkey (genus Aotus) was found to be highly susceptible to developing human malaria, making it an excellent experimental model for this disease. Microbes and parasites' (especially malaria) tremendous genetic variability became resolved during our malaria vaccine development, involving conserved peptides having high host cell binding activity (cHABPs); however, cHABPs are immunologically silent and must be specially modified (mHABPs) to induce a perfect fit into major histocompatibility complex (MHC) molecules (HLA in humans). Since malarial immunity is mainly antibody-mediated and controlled by the HLA-DRB genetic region, ?1000 Aotus have been molecularly characterised for MHC-DRB, revealing striking similarity between human and Aotus MHC-DRB repertories. Such convergence suggested that a large group of immune protection-inducing protein structures (IMPIPS), highly immunogenic and protection inducers against malarial intravenous challenge in Aotus, could easily be used in humans for inducing full protection against malaria. We highlight the value of a logical and rational methodology for developing a vaccine in an appropriate animal model: Aotus monkeys. © 2017 Elsevier Inc.application/pdfhttps://doi.org/10.1016/j.bbrc.2017.08.0120006291X10902104https://repository.urosario.edu.co/handle/10336/23518engElsevier B.V.1069No. 41062Biochemical and Biophysical Research CommunicationsVol. 491Biochemical and Biophysical Research Communications, ISSN:0006291X, 10902104, Vol.491, No.4 (2017); pp. 1062-1069https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027277802&doi=10.1016%2fj.bbrc.2017.08.012&partnerID=40&md5=1b77f83d10ac657442da298c3bea31f8Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHLA DRB1 antigenMalaria vaccineHLA antigen class 2Malaria vaccineAotusArticleControlled studyGenetic variabilityHumanHydrophobicityImmunofluorescence testImmunogenicityMalaria falciparumNonhumanPlasmodium falciparumPriority journalProton nuclear magnetic resonanceStatic electricityVaccinationWestern blottingAnimalAntigen antibody reactionAotidaeChemistryImmunologyAnimalsAntigen-Antibody ReactionsAotidaeHistocompatibility Antigens Class IIHumansMalaria VaccinesAnimal modelHLA-peptide bindingIMPIPSMalarial-vaccineMHC-DRStructural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humansarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Suárez C.F.Pabón L.Barrera A.Aza-Conde J.Patarroyo M.A.Patarroyo M.E.10336/23518oai:repository.urosario.edu.co:10336/235182022-05-02 07:37:21.040096https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
title Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
spellingShingle Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
HLA DRB1 antigen
Malaria vaccine
HLA antigen class 2
Malaria vaccine
Aotus
Article
Controlled study
Genetic variability
Human
Hydrophobicity
Immunofluorescence test
Immunogenicity
Malaria falciparum
Nonhuman
Plasmodium falciparum
Priority journal
Proton nuclear magnetic resonance
Static electricity
Vaccination
Western blotting
Animal
Antigen antibody reaction
Aotidae
Chemistry
Immunology
Animals
Antigen-Antibody Reactions
Aotidae
Histocompatibility Antigens Class II
Humans
Malaria Vaccines
Animal model
HLA-peptide binding
IMPIPS
Malarial-vaccine
MHC-DR
title_short Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
title_full Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
title_fullStr Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
title_full_unstemmed Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
title_sort Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
dc.subject.keyword.spa.fl_str_mv HLA DRB1 antigen
Malaria vaccine
HLA antigen class 2
Malaria vaccine
Aotus
Article
Controlled study
Genetic variability
Human
Hydrophobicity
Immunofluorescence test
Immunogenicity
Malaria falciparum
Nonhuman
Plasmodium falciparum
Priority journal
Proton nuclear magnetic resonance
Static electricity
Vaccination
Western blotting
Animal
Antigen antibody reaction
Aotidae
Chemistry
Immunology
Animals
Antigen-Antibody Reactions
Aotidae
Histocompatibility Antigens Class II
Humans
Malaria Vaccines
Animal model
HLA-peptide binding
IMPIPS
Malarial-vaccine
MHC-DR
topic HLA DRB1 antigen
Malaria vaccine
HLA antigen class 2
Malaria vaccine
Aotus
Article
Controlled study
Genetic variability
Human
Hydrophobicity
Immunofluorescence test
Immunogenicity
Malaria falciparum
Nonhuman
Plasmodium falciparum
Priority journal
Proton nuclear magnetic resonance
Static electricity
Vaccination
Western blotting
Animal
Antigen antibody reaction
Aotidae
Chemistry
Immunology
Animals
Antigen-Antibody Reactions
Aotidae
Histocompatibility Antigens Class II
Humans
Malaria Vaccines
Animal model
HLA-peptide binding
IMPIPS
Malarial-vaccine
MHC-DR
description More than 50 years ago the owl monkey (genus Aotus) was found to be highly susceptible to developing human malaria, making it an excellent experimental model for this disease. Microbes and parasites' (especially malaria) tremendous genetic variability became resolved during our malaria vaccine development, involving conserved peptides having high host cell binding activity (cHABPs); however, cHABPs are immunologically silent and must be specially modified (mHABPs) to induce a perfect fit into major histocompatibility complex (MHC) molecules (HLA in humans). Since malarial immunity is mainly antibody-mediated and controlled by the HLA-DRB genetic region, ?1000 Aotus have been molecularly characterised for MHC-DRB, revealing striking similarity between human and Aotus MHC-DRB repertories. Such convergence suggested that a large group of immune protection-inducing protein structures (IMPIPS), highly immunogenic and protection inducers against malarial intravenous challenge in Aotus, could easily be used in humans for inducing full protection against malaria. We highlight the value of a logical and rational methodology for developing a vaccine in an appropriate animal model: Aotus monkeys. © 2017 Elsevier Inc.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:43Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:43Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.bbrc.2017.08.012
dc.identifier.issn.none.fl_str_mv 0006291X
10902104
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23518
url https://doi.org/10.1016/j.bbrc.2017.08.012
https://repository.urosario.edu.co/handle/10336/23518
identifier_str_mv 0006291X
10902104
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1069
dc.relation.citationIssue.none.fl_str_mv No. 4
dc.relation.citationStartPage.none.fl_str_mv 1062
dc.relation.citationTitle.none.fl_str_mv Biochemical and Biophysical Research Communications
dc.relation.citationVolume.none.fl_str_mv Vol. 491
dc.relation.ispartof.spa.fl_str_mv Biochemical and Biophysical Research Communications, ISSN:0006291X, 10902104, Vol.491, No.4 (2017); pp. 1062-1069
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027277802&doi=10.1016%2fj.bbrc.2017.08.012&partnerID=40&md5=1b77f83d10ac657442da298c3bea31f8
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier B.V.
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167686264913920